1276 · Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H
56.65
HKDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
HK$420.54B
PE
55.40
EV/EBITDA
43.2
DIV Yield
0.3%
Payout Ratio
18%
MQV Rating
3Neutral
As at 24/07/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- Consensus Cheap
- HALO 200
- HALO All
- HALO Balance Sheet
- HALO Dividend Growth
- HALO Small
- Recent Price downgrade
- Short Term Trend - Short
Key Fundamentals
EPS 3 yr Growth
80.30%
EBITDA Margin
28.50%
Operating Cashflow
$12,241m
Free Cash Flow Return
21.00%
ROIC
14.30%
Interest Coverage
594.80
Quick Ratio
7.60
Performance
52 weeks range
Low 51.3 - 95.2
Trade Value (12mth)
US$8,994,061.00
1 week
2.91%
1 month
0.09%
YTD
-23.55%
1 year
-20.99%
All time high
95.20
Additional Data
Shares Outstanding (Fully Diluted)
6,598m
HALO Sector
Healthcare
Next Company Report Date
19-Apr-27
Next Ex Dividend Date
29-Apr-26
Next Dividend Pay Date
27-May-26
Reporting Currency
HKD
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Very Weak
Event
Very Strong
Halo Model
Mqv
Neutral
Garp
Neutral
Mqv Small
Neutral
Momentum
Price
Neutral
Earnings
Weak
Growth
Earnings
Neutral
Dividends
Very Strong
Quality
Capital Efficiency
Strong
Balance Sheet
Very Strong
Valuation
News & Announcements
No announcements available.